DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 1.59% to $8.32 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 3.07% to 26,683.94 and the Dow Jones Industrial Average rising 0.92% to 51,671.03.
This was the stock's third consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 59.53% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 0.17% to $5.88, Fortress Biotech Inc. (FBIO) rose 3.25% to $2.86, and Viking Therapeutics Inc. (VKTX) rose 3.06% to $29.63.
Trading volume (335,379) remained 135,929 below its 50-day average volume of 471,308.
Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 15, 2026 17:20 ET (21:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments